COMPANY

Origami Therapeutics, Inc.

HQ: San Diego, CA source · origamitherapeutics.com ↗ · West Coast

Keywords: neurology neurodegenerative diseases Huntington's disease Alzheimer's disease

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Deal Ipsen deal · amount not disclosed · announced Jan 30, 2026 Company release ↗
Source quote
- Jan 30, 2026 · Company release ↗
  “– Ipsen obtains exclusive option to global license a research program for a selective disease-modifying approach to neurodegenerative diseases SAN DIEGO–( BUSINESS WIRE )– Origami Therapeutics”

From the company’s own releases; this list is partial. All raises and deals

Aug 13, 2025 Grant Government grant — SBIR: $499,988 (annual award, as published), announced Aug 13, 2025. Agency: NIH/NINDS. Source: government award database. source ↗

Last 2 years.

Aug 13, 2025 Government grant — SBIR: $499,988 (annual award, as published), announced Aug 13, 2025. Agency: NIH/NINDS. Source: government award database. source ↗

Annual award amounts. Total $610K.

Aug 13, 2024 NIH award 5R43NS127716-02 FY2024: $107,065 awarded for that fiscal year; activity R43 (SBIR); PI HOFFMAN, BETH J; recipient as written: ORIGAMI THERAPEUTICS, INC., SAN DIEGO, CA. Characterization of small molecules t source ↗
Sep 14, 2023 NIH award 1R43NS127716-01A1 FY2023: $502,931 awarded for that fiscal year; activity R43 (SBIR); PI HOFFMAN, BETH J; recipient as written: ORIGAMI THERAPEUTICS, INC., SAN DIEGO, CA. Characterization of small molecules source ↗